By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Innovus Pharma 

4275 Executive Square
Suite 200
La Jolla  California  92037  U.S.A.
Phone: 858-964-5123 Fax: 858-964-2301



Company News
Innovus Pharma’s Partner Luminarie Receives Approval For Zestra For Female Sexual Arousal Disorder As A Medical Device I From Australia’s Therapeutic Goods Administration 7/20/2017 7:52:21 AM
Innovus Pharma To Enter The Oncology Supportive Care Market With An Exclusive License To Two GRAS-Listed OTC Compounds For Cachexia And Muscle Growth And Repair From University of Iowa Research Foundation 6/6/2017 7:15:12 AM
Innovus Pharma Announces Positive Pre-Clinical Synergistic Effects Of Vesele In Combination With Sildenafil (Viagra) On Nitric Oxide Production 6/1/2017 8:31:52 AM
Innovus Pharma Launches Allervarx, A Clinically Proven Supplement For The Relief Of Allergy Symptoms, In The United States 5/24/2017 7:40:45 AM
Innovus Pharma Files Its Product License Application In Canada For The Commercialization Of Vesele As A Natural Health Product To Help Improve Symptoms Of Sexual Dysfunction 5/18/2017 9:22:21 AM
Innovus Pharma Signs Exclusive License And Distribution Agreement With Densmore For Zestra In France And Belgium For Female Sexual Arousal Disorder 5/16/2017 8:28:58 AM
Innovus Pharma Reports Quarterly Revenue For The First Quarter 2017 Of $2.2 Million 5/15/2017 7:33:19 AM
Innovus Pharma Announces Commercial Partnership To Launch FlutiCare Under FDA Approved ANDA No. 207957 5/9/2017 6:20:50 AM
Innovus Pharma To Release First Quarter 2017 Financial Results And Provide Corporate Update On Friday, May 12, 2017 5/3/2017 9:02:38 AM
Innovus Pharma Launches ProstaGorx Product For Prostate Health Through Its Beyond Human Sales And Marketing Platform In The United States 5/1/2017 9:07:08 AM